I participated in the SPP and received a full allocation. I still hold all my shares. I do not plan on selling, these funds are not required. Further, I don't plan on selling because I view no fundamental changes to Bisantrene, the SP is frustrating but certainly feels disconnected to fair value.
I look forward to the coming strategy update as I feel unclear on what the path forward now looks like in new managements view, specifically time frames and I'm awaiting this update before committing further funds. The biggest gripe I sense is moving of the goal posts, for valid reasons of course but also delays in results and the flow on effect to a later transaction(s) / partnerships makes holders consider opportunity cost.
Nevertheless, I am excited to see Bisantrene / Zantrene come to market ASAP to help suffers.
General Comments / Chat, page-8121
-
- There are more pages in this discussion • 3,005 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.94 |
Change
0.000(0.00%) |
Mkt cap ! $330.4M |
Open | High | Low | Value | Volume |
$1.95 | $1.95 | $1.84 | $647.3K | 344.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3300 | $1.87 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.94 | 5654 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3300 | 1.870 |
4 | 46789 | 1.840 |
2 | 6500 | 1.830 |
2 | 649 | 1.820 |
1 | 829 | 1.805 |
Price($) | Vol. | No. |
---|---|---|
1.940 | 5654 | 2 |
1.950 | 7570 | 1 |
1.960 | 1350 | 1 |
1.990 | 4701 | 2 |
1.995 | 10037 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online